7 completed. 5 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow tavaborole: new trials by email Literature Review of tavaborole trials Research Report on tavaborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents Tavaborole 5% Topical Solution - Onychomycosis, Tinea Unguium | Phase 4 | Completed | Pfizer | 55 | 2015-10-22 | 2018-04-17 |
| Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) AN2690 - Onychomycosis | Phase 2 | Completed | Pfizer | 20 | 2007-03-31 | 2018-02-20 |
| Cumulative Irritation Test AN2690, AN2690 Solution, Vehicle, Sodium Lauryl Sulfate, 0.5% - Onychomycosis | Phase 1 | Completed | Pfizer | 37 | 2007-01-22 | 2019-04-09 |
| Study of Different Doses of a Novel Treatment for Onychomycosis AN2690, 2.5%, AN2690, 5%, AN2690, 7.5% - Distal, Subungual Onychomycosis | Phase 2 | Completed | Pfizer | 28 | 2006-06-30 | 2018-02-20 |
| Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis AN2690 - Onychomycosis | Phase 2 | Completed | Pfizer | 60 | 2006-06-30 | 2018-02-20 |
| Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I) AN2690 - Onychomycosis | Phase 2 | Completed | Pfizer | 15 | 2006-04-30 | 2019-02-21 |
| Study of Different Doses of a Novel Treatment for Onychomycosis AN2690, 2.5%, AN2690, 5%, AN2690, 7.5% - Distal, Subungual Onychomycosis | Phase 2 | Completed | Pfizer | 159 | 2006-02-28 | 2018-12-12 |
Onychomycosis (7)
Pfizer (7)
United States (6) · Mexico (1)